Emerging in the landscape of obesity therapy, retatrutide represents a peptides, retatrutide, glp, glp-2,glp-3, bpc-157, glutathione, tesamoreli unique strategy. Unlike many available medications, retatrutide functions as a dual agonist, simultaneously targeting both GLP-like peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) rec